Loading
MB
Marina Biotech, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Trieu Vuong, was filed 12 Jun 2017.
Marina Biotech, Inc.: what insiders have been doing
Marina Biotech, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Marina Biotech, Inc. has had no insider filing for more than a year; the last one goes back to 4 October 2018.
Since 2016, the database holds 7 purchases and no sales by insiders of the company.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
12
Thresholds
n/a
Buy Volume
€284,757
7 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
Revenue224.6k
Gross profit-140k-62% margin
Net income-1.9M-838.9% margin
Last declaration on 4 October 2018
Declarations12 total
500,000 shares@ US$0.50100.0% of flowCommon StockSEC:0001493152-18-014069:0
10,000 shares@ US$0.390.8% of flowCommon StockSEC:0001493152-17-006494:0
Canonical exit: 7 Sept 2017 (T+90)
20,000 shares@ US$0.391.5% of flowCommon StockSEC:0001493152-17-006346:0
Canonical exit: 6 Sept 2017 (T+90)
2,500 shares@ US$0.380.2% of flowCommon StockSEC:0001493152-17-006346:1
Canonical exit: 5 Sept 2017 (T+90)
22,500 shares@ US$0.42521.6% of flowCommon StockSEC:0001559647-17-000002:0
Canonical exit: 6 Jul 2017 (T+90)
13,000 shares@ US$0.3369.9% of flowCommon StockSEC:0001559647-17-000002:1
Canonical exit: 5 Jul 2017 (T+90)
97,550 shares@ US$0.31268.5% of flowCommon StockSEC:0001559647-17-000001:0
Canonical exit: 4 Jul 2017 (T+90)
862,068 shares@ US$0.2950.5% of flowCommon StockSEC:0001493152-17-001242:0
Canonical exit: 7 May 2017 (T+90)
100,000 shares0Common StockSEC:0001493152-17-001082:0
11,094,641 sharesCommon StockSEC:0001493152-16-015386:0
23,123,558 sharesCommon StockSEC:0001493152-16-015386:1
5,255,354 sharesCommon StockSEC:0001493152-16-015386:2
12 of 12 declarations
About Marina Biotech, Inc.
Marina Biotech, Inc. is a company focused on developing RNA-based therapies for genetic diseases and cancers. It is listed on NASDAQ under the symbol XNAS.
